Figure 8: Bar graph showing cumulative incidence of atherosclerotic change with time following implantation of BMS versus SES, and PES. Both sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) show earlier onset of neoatherosclerosis and a higher incidence of lesion formation as compared to bare metal stents (BMS). No drug-eluting stents (DESs) were available beyond 6 years. (Reproduced with permission from [12].)